Atlas Trials

Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors

Clinical trial NCT04989010 · UNKNOWN

Trial details

NCT number
NCT04989010
Sponsor
Wuxi No. 4 People's Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Solid Tumor, Adult
Start date
2021-08-01
Primary completion
2022-08-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.